Campbell David Alan
SEC CIK 1864158 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Pres, CEO, Dir | 264.7K | — | $6.61M | 11 | 2024-09-27 | 2026-07-31 |
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 20:00 | 2026-07-31 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | G - Gift | $0.00 | -123.8K | 264.7K | -32% | $0 | |
| D | 2026-07-10 20:00 | 2026-07-08 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | M - OptEx | $4.21 | +7,000 | 388.6K | +2% | +$29.5K |
| D | 2026-01-02 | 2026-01-02 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | A - Grant | $0.00 | +96.6K | 381.6K | +34% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $13.73 | -8,072 | 285.0K | -3% | -$110.8K |
| 2025-01-08 | 2025-01-07 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $60.00 | -5,000 | 293.1K | -2% | -$300.0K | |
| D | 2025-01-03 | 2025-01-02 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | A - Grant | $0.00 | +81.0K | 298.1K | +37% | $0 |
| 2024-12-27 | 2024-12-24 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $56.19 | -25.0K | 217.1K | -10% | -$1.40M | |
| 2024-12-03 | 2024-12-03 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $67.00 | -15.0K | 242.1K | -6% | -$1.00M | |
| M | 2024-11-27 | 2024-11-25 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $51.59 | -25.0K | 263.8K | -9% | -$1.29M |
| M | 2024-10-30 | 2024-10-28 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $53.54 | -25.0K | 282.1K | -8% | -$1.34M |
| M | 2024-09-27 | 2024-09-27 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO, Dir | S - Sale | $46.31 | -25.0K | 307.1K | -8% | -$1.16M |
Purchase Sale Sale after option exercise All abbreviations